Specialized clinical service access: A new model of addiction care that will offer comprehensive and coordinated service delivery
Study summary
Despite substance use causing significant harms and cost to our health care system, British Columbia's (BC) current addiction treatment system remains under-resourced and fragmented. To address this, Providence Health Care (PHC) is expanding clinical addiction services as part of the Road to Recovery Initiative (R2R). The proposed study aims to generate novel data to promote fully evidence-informed and coordinated substance use care in BC and beyond. This study will explore substance use treatment trajectories, identify challenges and areas for growth in addiction health services, characterize important features of patients accessing care, and improve our provincial capacity to promptly tailor approaches to care in response to the substance use crisis.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Aged 18 years or older
* Able to provide written informed consent
* A resident of British Columbia
* Willing to comply with study procedures
* An individual who has accessed one or more R2R services
Exclusion Criteria:
* Individuals who have an acute, severe mental health condition (e.g., psychosis) precluding the opportunity to provide full informed consent
* Individuals who have an acute, severe medical condition (e.g., intubation) precluding the opportunity to provide full informed consent
Primary outcome measure(s)
Substance use patterns following R2R access — 1 year Metrics include frequency of use in the 12-months following R2R access
Health care utilization patterns following R2R access — 1 year Metrics include the count of hospitalizations, readmissions, and emergency department visits.
Substance use treatment trajectories — 1 year Metrics include completion status of substance use treatment programs within 12 months after R2R access.
Health among study participants over time — 1 year Metrics include count of comorbidities in the 12 months following R2R access.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.